Pulished Date August, 2019
ID: 66
Share on
Share on

Middle East And Africa Veterinary Vaccines Market Analysis - By Type , By Technology, By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends & Forecast | 2019-2024

Pulished: August, 2019
ID: 66
Pages: 132

MEA Veterinary Vaccines Market Size & Growth Rate (2019- 2024)

The Middle East & Africa animal vaccines market is poised to reach USD 0.53 Billion by 2024 from USD 0.41 Billion in 2019, at a CAGR of 5.48% from 2019 to 2024.  Veterinary Vaccines are important and, at times, essential tools for prevention or control of given animal disease, but they require complementary actions like enabling legislation, investment for diagnostic, early response, public communication, etc.

The growing demand for livestock products (fuelled by population growth, increased urbanization and greater purchasing power of individuals in developing or middle- income countries) coupled with the necessity of complying with the standards of trade agreements, mean that governments in the Middle-East & Africa region must improve animal health in their countries.

The veterinary vaccine market has shown significant growth in recent years which can be attributed to increasing incidences of animal pandemics in the region. Contagious bovine pleuropneumonia is endemic in numerous areas of Africa and is suspected to occur occasionally in the Middle East. Rift Valley fever (RVF) is an insect-borne, multi-species zoonotic viral disease of livestock that has been exclusively conined to the African continent, but it began spreading to Middle-East in the past decade. This marks the estimation of further growth in the market in terms of livestock vaccine sales. However, International and regional collaboration have proven successful in the progressive control of these pandemics, e.g. the work of the Pan American Foot-and-Mouth Disease Centre in South America and the European Union FMD Commission which this region lacks. It makes adoption of regulations that much harder in the area. Rising maintenance costs for the storage of vaccines, increasing adoption of a vegetarian diet in major economies owing to the increased risk of obesity and other chronic diseases are key restraints of this market.

This research report segmented and sub-segmented into the following categories:

By Type: Livestock Vaccines and Companion Vaccines

By Technology: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines, and Conjugate Vaccines

By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Regionally, the Middle-East & Africa veterinary vaccines market has been categorized as livestock and companion vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines, and conjugate vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. Furthermore, on the basis of geography, the Middle-East & Africa Market is analyzed under major regions of the Middle-East and Africa.

Most promising companies of Middle East & Africa Veterinary Vaccines Market profiled in this report are:

  1. Bayer HealthCare AG
  2. Bioniche Animal Health Canada
  3. Sanofi Animal Health. Inc
  4. Biogenesis Bago SA
  5. Heska Corporation,
  6. Indian Immunologicals Ltd.
  7. Boehringer Ingelheim GmbH
  8. Zoetis, Novartis Animal Health. Inc
  9. Merck & Co. Inc
  10. Protein Sciences

 

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Livestock vaccines

                                                5.1.1.1 Bovine

                                                5.1.1.2 porcine

                                                5.1.1.3 Ovine

                                                5.1.1.4 Poultry

                                                5.1.1.5 Equine

                                5.1.2 Companion vaccines           

                                                5.1.2.1 canine

                                                5.1.2.2 feline

                5.2 Technology                

                                5.2.1 Live attenuated vaccines  

                                5.2.2 Inactivated vaccines            

                                5.2.3 Recombinant vaccines       

                                5.2.4 Toxoid vaccines    

                                5.2.5 Subunit vaccines  

                                5.2.6 DNA vaccines         

                                5.2.7 Conjugate vaccines             

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East               

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer Healthcare AG                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Bioniche Animal Health Canada                         

                8.3 Sanofi Animal Health Inc.                      

                8.4 Biogenesis Bago SA                 

                8.5 Heska Corporation                  

                8.6 Indian Immunologicals Ltd.                  

                8.7 Boehringer Ingelheim GmbH                              

                8.8 Novartis Animal Health, Inc.                

                8.9 Merck & Co. Inc.                       

                8.10 Protein Sciences                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  •  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Veterinary Vaccines Market By Region, From 2019-2024 ( USD Billion )
  2. Middle East & Africa Veterinary Vaccines Market By Type, From 2019-2024 ( USD Billion )
  3. Middle East & Africa Livestock vaccines Market By Region, From 2019-2024 ( USD Billion )
  4. Middle East & Africa Companion vaccines Market By Region, From 2019-2024 ( USD Billion )
  5. Middle East & Africa Veterinary Vaccines Market By Technology, From 2019-2024 ( USD Billion )
  6. Middle East & Africa Live attenuated vaccines Market By Region, From 2019-2024 ( USD Billion )
  7. Middle East & Africa Inactivated vaccines Market By Region, From 2019-2024 ( USD Billion )
  8. Middle East & Africa Recombinant vaccines Market By Region, From 2019-2024 ( USD Billion )
  9. Middle East & Africa Toxoid vaccines Market By Region, From 2019-2024 ( USD Billion )
  10. Middle East & Africa Subunit vaccines Market By Region, From 2019-2024 ( USD Billion )
  11. Middle East & Africa DNA vaccines Market By Region, From 2019-2024 ( USD Billion )
  12. Middle East & Africa Conjugate vaccines Market By Region, From 2019-2024 ( USD Billion )
  13. Middle East & Africa Livestock Vaccines Market By Type, From 2019-2024 ( USD Billion )
  14. Middle East & Africa Bovine Market By Region, From 2019-2024 ( USD Billion )
  15. Middle East & Africa porcine Market By Region, From 2019-2024 ( USD Billion )
  16. Middle East & Africa Ovine Market By Region, From 2019-2024 ( USD Billion )
  17. Middle East & Africa Poultry Market By Region, From 2019-2024 ( USD Billion )
  18. Middle East & Africa Equine Market By Region, From 2019-2024 ( USD Billion )
  19. Middle East & Africa Companion Animal Vaccines Market By Type, From 2019-2024 ( USD Billion )
  20. Middle East & Africa canine Market By Region, From 2019-2024 ( USD Billion )
  21. Middle East & Africa feline Market By Region, From 2019-2024 ( USD Billion )
  22. Middle East Veterinary Vaccines Market By Type, From 2019-2024 ( USD Billion )
  23. Middle East Veterinary Vaccines Market By Technology, From 2019-2024 ( USD Billion )
  24. Africa Veterinary Vaccines Market By Type, From 2019-2024 ( USD Billion )
  25. Africa Veterinary Vaccines Market By Technology, From 2019-2024 ( USD Billion )
  26. Middle East Livestock Vaccines Market By Type, From 2019-2024 ( USD Billion )
  27. Africa Livestock Vaccines Market By Type, From 2019-2024 ( USD Billion )
  28. Middle East Companion Animal Vaccines Market By Type, From 2019-2024 ( USD Billion )
  29. Africa Companion Animal Vaccines Market By Type, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample